Summary
The hypoxic cell radiosensitizer [2-14C] pimonidazole (2-nitro-α-(piperidinomethyl)-l-imidazole ethanol) was injected i.p. into pigmented mice and rats bearing transplanted rhabdomyosarcoma. The injected dose level was 200 mg/kg, and the delivered activity was 96 μCi/kg. Whole-body autoradiography was carried out on all animals. We noted an extensive whole-body distribution of radioactivity. At short intervals, the autoradiograms were characterized by an accumulation of radioactivity in the metabolic and exretory organs (liver, kidney, urinary tract, and intestinal content) as well as in lymphomyeloid tissues (thyroid gland, suprarenal gland, and hypophysis) and salivary glands. In pigmented mice, the uveal and biliary tracts were the highest labelled. The liver and particularly the renal medulla were identified as sites of retention of radioactivity. In the tumor the radioactivity was detected only in peripheral regions, with higher uptake in viable zones than in necrotic islets.
Similar content being viewed by others
Abbreviations
- MISO:
-
misonidazole
- [14C] ou [14C] Ro, [14C]:
-
Ro 03-8799 plus Ro 03-8799-derived [14C]-labelled metabolites
References
Akel G, Benard P, Canal P, Soula G (1986) Distribution and tumor penetration properties of radiosensitizer [2-14C] misonidazole (Ro 07-0582) in mice and rats as studied by wholebody autoradiography. Cancer Chemother Pharmacol 17: 121
Allen JG, Dische S, Lenox-Smith I, Malcolm SL, Saunders MI (1984) The pharmacokinetics of a new radiosensitizer, Ro 03-8799, in humans. Eur J Clin Pharmacol 27: 483
Blasberg R, Horowitz M, Strong J, Molmar P, Patlak C, Owens E, Fenstermacher J (1985) Regional measurements of [14C] misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors. Cancer Res 45: 1692
Dische S, Saunders MI, Lee ME, Admas GE, Flockhart IR (1977) Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer 35: 567
Dische S, Saunders MI, Dunphy EP, Bennett MH, Desrochers C, Stratford MRL, Minchinton AI, Orchard RA (1986a) Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799. Int J Radiat Oncol Biol Phys 12: 1109
Dische S, Saunders MI, Bennett MH, Wardman P (1986b) A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799. Br J Radiol 59: 911
Durand S, Benard P, Braun JP (1980) Ethionine and methionine distribution and toxicity in the rat kidney. Toxicol Lett 5: 257
Gessner T, Trudnowski R, Rico R, Rempel J (1976) Passage of intravenously administered pethidine into gastric juice in man. J Pharm Pharmacol 28: 79
Lindquist NG (1973) Accumulation of drugs on melanin. Acta Radiol 325 (Suppl): 1
Malcolm SL, Lee A, Groves JK (1983) HPLC analysis of Ro 03-8799 in biological samples. J Chromatogr 273: 327
Newman HFV, Bleehen NM, Workman P (1986) A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokinetics. Int J Radiat Oncol Biol Phys 12: 1113
Rich TA, Dische S, Saunders MI, Stratford MRL, Minchinton A (1981) A serial study of the concentration of misonidazole in human tumors correlated with histologic structure. Int. J Radiat Oncol Biol Phys 7: 197
Roberts JT, Bleehen NM, Walton MI, Workman P (1986) A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics. Br J Radiol 59: 107
Saunders MI, Dische S, Fermont D, Bishop A, Lenox-Smith I, Allen JG, Malcolm SL (1982) The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study. Br J Cancer 46: 706
Saunders MI, Anderson PJ, Bennett MH, Dische S, Minchinton A, Stratford MRL, Tothill M (1984) The clinical testing of Ro 03-8799 pharmacokinetics, toxicology, tissue and tumor concentrations. Int J Radiat Oncol Biol Phys 10: 1759
Smithen CE, Clarke ED, Dale JA, Jacobs RS, Wardman P, Watts ME, Woodcock M (1980) Novel (nitro-1-imidazolyl) alkanolamines as potential radiosensitizers with improved therapeutic properties. In: Brady LH (ed) Radiation sensitizers: their use in the clinical management of cancer. Masson, New York pp 22
Sweeney FL, Pot-Derpum J, Poupon MF, Chouroulinkov I (1982) Heterogeneity of the growth and metastatic behavior of cloned cell lines derived from a primary rhabdomyosarcoma. Cancer Res 42: 3776
Ullberg S (1977) The technique of whole-body autoradiographic study. Sci Tools 2
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laurent, F., Benard, P., Canal, P. et al. Autoradiographic distribution of [14C]-labelled pimonidazole in rhabdomyosarcoma-bearing rats and pigmented mice. Cancer Chemother. Pharmacol. 22, 308–315 (1988). https://doi.org/10.1007/BF00254237
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254237